Expand OCGN Menu
OCGN MENU

OCGN Latest Press Releases

-- December 10, 2025 --

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit Globe Newswire 9:20 AM

-- November 20, 2025 --

Ocugen CEO to Present at NobleCon21-Noble Capital Markets' Twenty-First Annual Emerging Growth Equity Conference Globe Newswire 7:02 AM

-- November 5, 2025 --

Ocugen Provides Business Update with Third Quarter 2025 Financial Results Globe Newswire 6:30 AM

-- October 23, 2025 --

Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results Globe Newswire 7:30 AM

-- October 2, 2025 --

Ocugen to Present at Industry and Investor Conferences in October 2025 Globe Newswire 7:30 AM

-- September 15, 2025 --

Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea Globe Newswire 6:03 AM

-- September 2, 2025 --

Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025 Globe Newswire 7:02 AM

-- August 13, 2025 --

Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST-Modifier Gene Therapy for Stargardt Disease Globe Newswire 6:27 AM

-- August 12, 2025 --

Ocugen, Inc. Announces Closing of $20 Million Registered Direct Offering of Common Stock and Warrants Globe Newswire 3:45 PM

-- August 8, 2025 --

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants Globe Newswire 5:03 PM

-- August 1, 2025 --

Ocugen Provides Business Update with Second Quarter 2025 Financial Results Globe Newswire 8:25 AM
Market Data Delayed 15 Minutes